Cyber security in 2021
Based on the current global macroeconomics construct, there is little sign that budgets will rise during H1 2021. That said, ever increasingly complex automated attackers are identifying new vulnerabilities and…
Source: www.cshub.com and Read More
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
